Zeda will produce OIC’s implant designs, fortifying and accelerating its mission to provide accessible trauma implants to patients on a worldwide scale.

CartiHeal is the developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee.

Enovis’ $844 million acquisition of LimaCorporate is expected to elevate the company’s recon segment to $1 billion in annual sales.

The company will acquire a majority interest in TriMed and enter a strategic relationship with Extremity Medical.

The transaction will allow ZimVie to streamline operations and sharpen its focus as a well-positioned, pure-play dental company in higher-growth end markets.

SERF is recognized worldwide for its innovations in hip implants, including the invention of the original Dual Mobility Cup.

Orthopedic M&A is more active and has higher multiples than general medtech, but economic conditions will limit growth for now.

Vyrsa manufactures and supports a complete portfolio of FDA-cleared sacroiliac joint fusion devices.

TeDan produces surgical access systems with a specialty focus in spine, neuro, orthopedic and cardiothoracic surgery.

Agili-C is a novel sports medicine technology developed to treat cartilage regeneration in the knee.